Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician

被引：10
|
作者：
Lohrmann, Graham M. [1 ]
Atwal, Danish [1 ]
Augoustides, John G. [2 ]
Askar, Wajih [3 ]
Patel, Prakash A. [2 ]
Ghadimi, Kamrouz [4 ,5 ]
Makar, Gerges [1 ]
Gutsche, Jacob T. [2 ]
Shamoun, Fadi E. [1 ]
Ramakrishna, Harish [3 ]
机构：
[1] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA
[2] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA
[3] Mayo Clin, Dept Anesthesiol, Scottsdale, AZ USA
[4] Duke Univ, Med Ctr, Div Cardiothorac Anesthesiol, Durham, NC USA
[5] Duke Univ, Med Ctr, Div Crit Care, Durham, NC USA
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2016年 / 30卷 / 03期
关键词：
novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIM; idarucizumab; andexanet; aripazine; PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ATRIAL-FIBRILLATION; DABIGATRAN ETEXILATE; CARDIAC-SURGERY; CLINICAL-TRIAL; IDARUCIZUMAB; WARFARIN; RIVAROXABAN;
D O I：
10.1053/j.jvca.2016.01.005
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：823 / 830
页数：8
相关论文
共 50 条
  • [1] New oral anticoagulants and their reversal agents
    Laslo, Crista L.
    Stoian, Anca Pantea
    Socea, Bogdan
    Paduraru, Dan N.
    Bodean, Oana
    Socea, Laura I.
    Neagu, Tiberiu Paul
    Stanescu, Ana Maria Alexandra
    Marcu, Drags
    Diaconu, Camelia C.
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (02): : 195 - 201
  • [2] New Oral Anticoagulants and Their Reversal Agents
    Morotti, Andrea
    Goldstein, Joshua N.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (11)
  • [3] New Oral Anticoagulants and Their Reversal Agents
    Andrea Morotti
    Joshua N. Goldstein
    Current Treatment Options in Neurology, 2016, 18
  • [4] Reversal Agents in Development for the New Oral Anticoagulants
    Costin, James
    Ansell, Jack
    Laulicht, Bryan
    Bakhru, Sasha
    Steiner, Solomon
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 19 - 24
  • [5] New Reversal Agents for Oral Anticoagulants on the Horizon
    Mazur, Marcus D.
    Sivakumar, Walavan
    Taussky, Philipp
    Park, Min S.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1506 - 1507
  • [6] New anticoagulants, reversal agents, and clinical considerations for perioperative practice
    Hart, Brendon M.
    Ferrell, Stephane M.
    Motejunas, Mark W.
    Bonneval, Lauren A.
    Cornett, Elyse M.
    Urman, Richard D.
    Kaye, Alan D.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2018, 32 (02) : 165 - 178
  • [7] DIRECT ORAL ANTICOAGULANTS: NEW PERSPECTIVES ON REVERSAL AGENTS
    Imberti, D.
    Fontana, M.
    Benedetti, R.
    BLOOD TRANSFUSION, 2016, 14 : S691 - S694
  • [8] New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents
    Patterson, William
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (04) : 168 - 168
  • [9] New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents
    Rahman, Atifur
    Latona, Jilani
    AUSTRALIAN FAMILY PHYSICIAN, 2014, 43 (12) : 861 - 866
  • [10] Reversal Agents for the Direct Oral Anticoagulants
    Ansell, Jack E.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1085 - +
12345